Small-Cap Stock Under ₹ 20 to Raise ₹ 1500 Crore Via Equites, Acquires us Subsidian

Stock Market Today: Small-Cap Stock under 20 is set to raise 1500 Crore Via Equites. The company also Acquired Incorpation of a company in the united states of America and canada. Check Details about Sudarshan Pharma Industries Limited.

Small-Cap Stock under 20 Sudarshan Pharma Industries – Fundraise

Sudarshan Pharma Industries Announced on the Exchanges on 9 June 2025, that board of directors has approved the proposal to raise funds’ by the way of electricity shares and equity shares and or raising through the Eligible Securities (Convertible Or Non-Convertible) Through Permissible Modes in One or More Translations in the Course of Domestic and/Or or International Offerings in OR More more than markets. This will be by way of a public issue, preferentiial issue, qualified institutions place, private placement, or combination thereof of right shares of the company having a factor of re1 rescue Value Rupee Rupee Through an issue of global depository receipts, Foreign currency convertible debents, and other such instruments.

Small-Cap Stock under 20 Sudarshan Pharma Industries Plans on Raising 1500 Crore.

Small-Cap Stock under 20 Sudarshan Pharma Industries Acquisition Details

The Sudarshan Pharma also informed us that board of directors of the company has approved the incorrectly in the united states of America with the proposed name ..Sudarshan INDUSTRIS LLC ” Name as may be approved by us authorities, which will be a wholy owned subsidiary of the company.

Also, Sudarshan Pharma’s Board of Directors has approved the incorption of a which-out subsidiary company in canada, which will be a subsidian of the company.

Small-Cap Stock under 20 Sudarshan Pharma Industries – Share Price Movement

Small-Cap Stock under 20 Sudarshan Pharma Industries, Whose Share Price Was Trading At 29.05 Levels on Friday, has Risen 295% in a year, and hence sudarshan pharma industrys has given multibagger returns to the investors.

Disclaimer: This story is for educational purposes only. The views and recommendations made about individual analysts or broking companies and not of mint. We Advise Investors to Check With Certified Experts Before Making Any Investments Decisions.